Game of clones: decipher lineage plasticity in hormone-driven cancers

Amanda Leonita1,2, Siyuan Cheng1, Joshua Warrick2,3

  • 1Department of Urology, Yale University School of Medicine, New Haven, CT, 06511, USA.

Insights

Lineage plasticity allows cancer cells to resist hormone therapies by changing their identity. Understanding these cell fate transitions is key to developing new treatments for hormone-driven cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Hormone-driven cancers (prostate, breast, endometrial) rely on nuclear hormone receptors.
  • Therapies targeting hormone signaling face resistance due to lineage plasticity.
  • Lineage plasticity involves tumor cells abandoning their identity for alternative fates.

Purpose of the Study:

  • Define regulatory programs governing cell fate transitions in hormone-driven cancers.
  • Understand the stability, directionality, and therapeutic vulnerability of lineage plasticity.
  • Propose a framework for understanding and targeting lineage plasticity.

Main Methods:

  • Integrative multi-omics (genomic, transcriptomic, epigenomic, proteomic, chromatin).
  • Single-cell and spatial technologies.
  • Artificial intelligence and machine learning for gene regulatory circuit reconstruction.

Main Results:

  • Identified transcriptional and epigenetic programs destabilizing lineage fidelity.
  • Revealed intermediate states, rare subpopulations, and microenvironmental influences on plasticity.
  • Connected molecular programs to phenotypic outcomes using AI/ML.

Conclusions:

  • Lineage plasticity is a critical mechanism of resistance in hormone-driven cancers.
  • Multi-omics, single-cell, and AI/ML approaches are vital for studying plasticity.
  • Understanding regulatory programs offers opportunities for biomarkers and therapeutic strategies to limit resistance.

Related Concept Videos

Lineage Commitment01:21

Lineage Commitment

Commitment is the  process whereby stem cells:
3.4K
Forced Transdifferentiation01:28

Forced Transdifferentiation

Transdifferentiation, also known as lineage reprogramming, was first discovered by Selman and Kafatos in 1974 in silkmoths. They observed that the moths’ cuticle-producing cells transformed into salt-producing cells. Many such cases of natural transdifferentiation occur in organisms. In humans, pancreatic alpha cells can become beta cells. In newts, the loss of the eye’s lens causes the pigmented epithelial cells to transdifferentiate into the lens cells.
Artificial...
1.5K
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
7.1K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
5.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.3K
Cadherins in Tissue Organization01:19

Cadherins in Tissue Organization

The cadherins are a superfamily of cell adhesion molecules comprising over 180 variants, with specific tissues expressing a particular combination of cadherin types. Cadherins generally exhibit homophilic binding; i.e., cadherins on one cell bind to cadherins of the same or closely related type on another cell. Thus, cells of the same type have a specific affinity to bind to each other and sort themselves into clusters to form tissues.
Cell Sorting During Development
Cell sorting plays an...
3.4K